Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Eagle Pharmaceuticals enters biosimilars market with acquisition of Arsia Therapeutics

Executive Summary

Eagle Pharmaceuticals Inc. acquired private biotech company Arsia Therapeutics Inc. for total consideration of up to $78mm in cash, stock, and potential earn-out payments. Along with the acquisition, Eagle will also establish a biologics innovation center in Kendall Square in Cambridge, MA.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register